Haleon (HLN) Stock Forecast & Price Target

GBX 330 +0.90 (+0.27%)

As of 04:18 AM Eastern

Compare

Haleon - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 6 Analyst Ratings

Sell
1

Hold
1

Buy
4

Based on 6 Wall Street analysts who have issued ratings for Haleon in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 6 analysts, 1 has given a sell rating, 1 has given a hold rating, and 4 have given a buy rating for HLN.

Consensus Price Target

GBX 398.67

According to the 6 analysts' twelve-month price targets for Haleon, the average price target is GBX 398.67. The highest price target for HLN is GBX 512, while the lowest price target for HLN is GBX 335. The average price target represents a forecasted upside of 20.81% from the current price of GBX 330.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for HLN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Haleon and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HLN Analyst Ratings Over Time

Type	Current Forecast 5/15/25 to 5/15/26	1 Month Ago 4/15/25 to 4/15/26	3 Months Ago 2/14/25 to 2/14/26	1 Year Ago 5/15/24 to 5/15/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)	1 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	GBX 398.67	GBX 407	GBX 407.83	GBX 457
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy

HLN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

HLN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Haleon Stock vs. The Competition

Type	Haleon	Medical Companies
Consensus Rating Score	2.50	2.30
Consensus Rating	Moderate Buy	Hold
News Sentiment Rating	Neutral News See Recent HLN News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Action	Rating	Price Target	Report Date Upside/Downside
5/5/2026	Jefferies Financial Group 2 of 5 stars	Lower Target	Buy	GBX 450 ➝ GBX 400	+19.12%
4/30/2026	Royal Bank Of Canada 3 of 5 stars	Reiterated Rating	Sector perform	GBX 370 ➝ GBX 370	+8.63%
4/30/2026	Berenberg Bank 1 of 5 stars	Reiterated Rating	Buy	GBX 512 ➝ GBX 512	+49.86%
1/22/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Target	Buy	GBX 340 ➝ GBX 335	-10.76%
11/26/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Target	Underweight	GBX 315 ➝ GBX 335	-9.97%
9/10/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral ➝ Buy	GBX 440	+18.44%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 04:40 AM ET.

Should I Buy Haleon Stock? HLN Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, May 11, 2026. Please send any questions or comments about these Haleon pros and cons to contact@marketbeat.com.

Haleon
Bull Case

Here are some ways that investors could benefit from investing in Haleon plc:

The current stock price is around GBX 335, which presents a potential upside based on analysts' price targets.
Haleon plc has a strong portfolio of well-known brands in consumer health, including Advil and Centrum, which are built on trusted science and innovation.
Recent analyst ratings indicate a consensus of "Moderate Buy," suggesting positive sentiment among investment professionals.
The company has reported a solid earnings per share (EPS) forecast for the current fiscal year, indicating potential profitability and growth.
Haleon plc operates in a stable industry focused on essential health products, which can provide resilience during economic downturns.

Haleon
Bear Case

Investors should be bearish about investing in Haleon plc for these reasons:

Recent price target reductions by analysts, including a cut from GBX 450 to GBX 400, may indicate concerns about future performance.
The company has a relatively high debt-to-equity ratio, which could pose risks in terms of financial stability and flexibility.
Insider selling activity, such as the recent sale of shares by an executive, may raise red flags about the company's future prospects.
Market volatility and economic uncertainties can impact consumer spending on health products, potentially affecting sales.
Some analysts have issued lower target prices, which could reflect a lack of confidence in the company's growth trajectory.

HLN Forecast - Frequently Asked Questions

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Haleon is GBX 398.67, with a high forecast of GBX 512 and a low forecast of GBX 335.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last year. There is currently 1 sell rating, 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" HLN shares.

According to analysts, Haleon's stock has a predicted upside of 20.81% based on their 12-month stock forecasts.

Haleon has been rated by research analysts at Berenberg Bank, Jefferies Financial Group, and Royal Bank Of Canada in the past 90 days.

Analysts like Haleon more than other "medical" companies. The consensus rating for Haleon is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how HLN compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Haleon Recommendations

This page (LON:HLN) was last updated on 5/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Haleon (HLN) Stock Forecast & Price Target

Haleon - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

HLN Analyst Ratings Over Time

HLN Analyst Recommendations By Month

HLN Price Targets by Month

Haleon Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Haleon Stock? HLN Pros and Cons Explained

Haleon
Bull Case

Haleon
Bear Case

HLN Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Haleon Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Haleon (HLN) Stock Forecast & Price Target

Haleon - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

HLN Analyst Ratings Over Time

HLN Analyst Recommendations By Month

HLN Price Targets by Month

Haleon Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Haleon Stock? HLN Pros and Cons Explained

Haleon Bull Case

Haleon Bear Case

HLN Forecast - Frequently Asked Questions

What is Haleon's forecast for 2026?

Should I buy or sell Haleon stock right now?

Does Haleon's stock price have much upside?

What analysts cover Haleon?

Do Wall Street analysts like Haleon more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Haleon Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Haleon
Bull Case

Haleon
Bear Case